近千万元种子轮融资！AI超声医美平台

Core Insights - Nodinxian Medical Technology Co., Ltd. has completed nearly 10 million RMB in seed round financing, led by Maike Fund, to optimize engineering prototypes, advance clinical validation, expand the team, and prepare for registration pathways [1] - The company aims to leverage non-invasive AI-driven ultrasound technology to create a differentiated competitive advantage in the medical aesthetics sector [1][2] Market Situation - The light medical aesthetics market in China is growing rapidly, with a compound annual growth rate of 19.4%, expected to exceed 237.5 billion RMB by 2026 [2] - There are over 19,000 medical beauty institutions in China, with nearly 90% being private, indicating a vast downstream application landscape [2] - The market is shifting from "energy intensity" to "path precision" and "repeatable efficacy," driven by regulatory tightening on ultrasound treatment devices [3] Company Overview - Nodinxian was established in late 2024, with a team experienced in medical imaging, AI algorithms, and device development [5] - The company is headquartered in Zhangjiang, Shanghai, and aims to create an international, modular ultrasound shaping and repair platform [5] Product Introduction - The product technology roadmap includes key modules and capabilities focused on AI ultrasound applications [6] Differentiated Advantages and Innovations - The company’s technology includes three-dimensional individualized energy planning, AI-assisted guidance systems, non-invasive ultrasound control, and plastic data tracking management [9] - The first engineering prototype has been completed and is currently undergoing internal validation and optimization [9] Current Progress and Roadmap - The company plans to initiate NMPA Class III device registration applications in 2026 and pursue FDA certification for international expansion [9]